Remdesivir Shows Promising Results In Leaked Report But Doubts Remain
No Comparator Arm One Issue?
Gilead’s front-running antiviral to fight the coronavirus has shown rapid improvement in severe patients’ symptoms in one US study but some are not convinced.
